ERBB receptor tyrosine kinases and cellular radiation responses.
Ionizing radiation induces in autocrine growth-regulated carcinoma and malignant glioma cells powerful cytoprotective responses that confer relative resistance to consecutive radiation exposures. Understanding the mechanisms of these responses should provide new molecular targets for tumor radiosensitization. ERBB and other receptor Tyr kinases have been identified as immediate early response gene products that are activated by radiation within minutes, as by their physiological growth factor ligands, and induce secondary stimulation of cytoplasmic protein kinase cascades. The simultaneous activation of all receptor Tyr kinases and nonreceptor Tyr kinases leads to complex cytoprotective responses including increased cell proliferation, reduced apoptosis and enhanced DNA repair. Since these responses contribute to cellular radioresistance, ERBB1, the most extensively studied ERBB receptor, is examined as a target for tumor cell radiosensitization. The three methods of ERBB1 inhibition include blockade of growth factor binding by monoclonal antibody against the ligand-binding domain, inhibition of the receptor Tyr kinase-mediating receptor activation, and overexpression of a dominant-negative epidermal growth factor receptor-CD533 that lacks the COOH-terminal 533 amino acids and forms nonfunctional heterodimeric complexes with wild-type receptors. All the three approaches enhance radiation toxicity in vitro and in vivo. The different mechanisms of inhibition have contributed to the understanding of cellular responses to radiation, vary in relative effectiveness and pose different challenges for translation.
Schmidt-Ullrich
Rupert K
RK
Radiation Oncology Department, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA. rullrich@hsc.vcu.edu
Contessa
Joseph N
JN
Lammering
Guido
G
Amorino
George
G
Lin
Peck-Sun
PS
D000818:Animals; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000528:radiation effects*
D020794:Receptor Protein-Tyrosine Kinases